| - SMTL ID
- 6b0t.1
- Ligands
- 4-methyl-N-(1-{[4-(trifluoromethyl)phenyl]methyl}-1H-indazol-3-yl)-1,2-oxazole-5-carboxamide
- Polypeptides
- Fascin
- Oligo-state
- monomer
|
| - SMTL ID
- 6b0t.2
- Ligands
- 4-methyl-N-(1-{[4-(trifluoromethyl)phenyl]methyl}-1H-indazol-3-yl)-1,2-oxazole-5-carboxamide
- Polypeptides
- Fascin
- Oligo-state
- monomer
|
| - SMTL ID
- 6b0t.3
- Ligands
- 4-methyl-N-(1-{[4-(trifluoromethyl)phenyl]methyl}-1H-indazol-3-yl)-1,2-oxazole-5-carboxamide
- Polypeptides
- Fascin
- Oligo-state
- monomer
|
| - SMTL ID
- 6b0t.4
- Ligands
- 4-methyl-N-(1-{[4-(trifluoromethyl)phenyl]methyl}-1H-indazol-3-yl)-1,2-oxazole-5-carboxamide
- Polypeptides
- Fascin
- Oligo-state
- monomer
|
| - SMTL ID
- 6b0t.5
- Ligands
- 4-methyl-N-(1-{[4-(trifluoromethyl)phenyl]methyl}-1H-indazol-3-yl)-1,2-oxazole-5-carboxamide
- Polypeptides
- Fascin
- Oligo-state
- monomer
|
| - SMTL ID
- 6b0t.6
- Ligands
- 4-methyl-N-(1-{[4-(trifluoromethyl)phenyl]methyl}-1H-indazol-3-yl)-1,2-oxazole-5-carboxamide
- Polypeptides
- Fascin
- Oligo-state
- monomer
|